Abstract
Primary cardiac tumors (PCTs) are extremely rare entities. More than half of PCTs are benign, with myxoma being the most common tumor. Generally, simple tumor resection is the treatment of choice for benign PCTs since it has promising results that yield low complication and recurrence rates. However, in the COVID-19 pandemic era, the mitigation protocols and/or concurrent COVID-19 infection should be taken into account in patient management for the best overall outcome. To our knowledge, this is the first case report of a patient with a left atrial myxoma and systemic embolism complication in the form of an ischemic stroke, with a concurrent confirmed COVID-19 delta variant infection.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference16 articles.
1. Frequency of primary tumors of the heart.;K Reynen;Am. J. Cardiol.,1996 Jan 1
2. Primary cardiac tumors.;M Leja;Tex. Heart Inst. J.,2011
3. Primary malignancies of the heart and pericardium.;I Burazor;Clin. Cardiol.,2014 Sep
4. Cardiac tumors–diagnosis and surgical treatment.;A Hoffmeier;Dtsch. Arztebl. Int.,2014
5. Clinical presentation and treatment of cardiac myxoma in 153 patients.;A Karabinis;Medicine (Baltimore).,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献